Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PTPI, Q2 2026
No superinvestor reported holding PTPI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Petros Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 (view filing)6:13 AM ET | Dec 22, 2021 | 12 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +145.8K | $3.43 | +$500.0K | +2.6%5.70M after | |
| Jan 3, 2022 (view filing)6:13 AM ET | Dec 22, 2021 | 12 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchase | +109.3K | $0.00 | $0 | –109.3K after | Derivative |
| Nov 30, 2021 (view filing)2:49 PM ET | Nov 29 | 1 day | Shulman John D and 4 othersDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +500.0K | $3.00 | +$1.50M | +9.9%5.56M after | |
| Nov 30, 2021 (view filing)2:49 PM ET | Nov 29 | 1 day | Shulman John D and 4 othersDirector, 10% Owner | PPurchase | +375.0K | $0.00 | $0 | –375.0K after | Derivative |
| Oct 21, 2021 (view filing)8:47 AM ET | Oct 18 | 3 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +1.66M | $1.72 | +$2.85M | +48.9%5.06M after | |
| Oct 21, 2021 (view filing)8:47 AM ET | Oct 18 | 3 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchase | +1.66M | $0.00 | $0 | –1.66M after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Petros Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding PTPI in 13F filings for Q2 2026.